|
Volumn 24, Issue 9, 2010, Pages 1374-1377
|
Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to-child HIV transmission
a b c d d e |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
DISEASE COURSE;
DRUG EFFICACY;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
MATERNAL MORTALITY;
PERINATAL INFECTION;
POLYMERASE CHAIN REACTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REFERENCE VALUE;
VERTICAL TRANSMISSION;
VIRUS LOAD;
VIRUS TRANSMISSION;
WORLD HEALTH ORGANIZATION;
ZAMBIA;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
INFECTIOUS DISEASE TRANSMISSION, VERTICAL;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
VIRAL LOAD;
WORLD HEALTH ORGANIZATION;
ZAMBIA;
|
EID: 77952923689
PISSN: 02699370
EISSN: 14735571
Source Type: Journal
DOI: 10.1097/QAD.0b013e3283394f5b Document Type: Article |
Times cited : (54)
|
References (6)
|